117 related articles for article (PubMed ID: 8224652)
41. Role of gap junctions modulating hepatic vascular tone in cirrhosis.
Hernández-Guerra M; González-Méndez Y; de Ganzo ZA; Salido E; García-Pagán JC; Abrante B; Malagón AM; Bosch J; Quintero E
Liver Int; 2014 Jul; 34(6):859-68. PubMed ID: 24350605
[TBL] [Abstract][Full Text] [Related]
42. Mucosal blood flow and modified vascular responses to norepinephrine in the stomach of rats with liver cirrhosis.
Kitano S; Koyanagi N; Sugimachi K; Kobayashi M; Inokuchi K
Eur Surg Res; 1982; 14(3):221-30. PubMed ID: 7117327
[TBL] [Abstract][Full Text] [Related]
43. Effect of misoprostol in ethanol-induced liver injury.
Flisiak R; Prokopowicz D; Lapiński W
Pol J Pathol; 1995; 46(3):187-90. PubMed ID: 7496739
[TBL] [Abstract][Full Text] [Related]
44. Zinc L-carnosine protects against mucosal injury in portal hypertensive gastropathy through induction of heat shock protein 72.
Mikami K; Otaka M; Watanabe D; Goto T; Endoh A; Miura K; Ohshima S; Yoneyama K; Sato M; Shibuya T; Segawa D; Kataoka E; Yoshino R; Takeuchi S; Sato W; Odashima M; Watanabe S
J Gastroenterol Hepatol; 2006 Nov; 21(11):1669-74. PubMed ID: 16984587
[TBL] [Abstract][Full Text] [Related]
45. Effect of sirolimus on liver cirrhosis and hepatic encephalopathy of common bile duct-ligated rats.
Wu KC; Huang HC; Chang T; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Lee FY; Chang CC; Lee SD
Eur J Pharmacol; 2018 Apr; 824():133-139. PubMed ID: 29444470
[TBL] [Abstract][Full Text] [Related]
46. Effects of prostaglandin E1, E2 and 16,16-dimethyl-E2 on gastric mucosal microcirculation and basal acid output in the rat.
Holm-Rutili L
Acta Physiol Scand; 1986 Jul; 127(3):313-21. PubMed ID: 3463127
[TBL] [Abstract][Full Text] [Related]
47. Protective effect of omeprazole on gastric mucosal of cirrhotic portal hypertension rats.
Gao W; Li HY; Wang LX; Hao LJ; Gao JL; Zheng RJ; Cai CJ; Si YL
Asian Pac J Trop Med; 2014 May; 7(5):402-6. PubMed ID: 25063070
[TBL] [Abstract][Full Text] [Related]
48. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
49. The effect of intraportal administration of prostaglandin E1 on liver blood flow and liver function.
Inagaki H; Kurokawa T; Nonami T; Miwa T; Nakao A; Takagi H
Hepatogastroenterology; 1999; 46(29):2909-13. PubMed ID: 10576371
[TBL] [Abstract][Full Text] [Related]
50. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats].
Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839
[TBL] [Abstract][Full Text] [Related]
51. Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
Tripathi DM; Erice E; Lafoz E; García-Calderó H; Sarin SK; Bosch J; Gracia-Sancho J; García-Pagán JC
Am J Physiol Gastrointest Liver Physiol; 2015 Sep; 309(5):G301-9. PubMed ID: 26138461
[TBL] [Abstract][Full Text] [Related]
52. HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects.
Klein S; Van Beuge MM; Granzow M; Beljaars L; Schierwagen R; Kilic S; Heidari I; Huss S; Sauerbruch T; Poelstra K; Trebicka J
J Hepatol; 2012 Dec; 57(6):1220-7. PubMed ID: 22878469
[TBL] [Abstract][Full Text] [Related]
53. Effect of neonatal capsaicin treatment on haemodynamics and renal function in cirrhotic rats.
Li Y; Song D; Zhang Y; Lee SS
Gut; 2003 Feb; 52(2):293-9. PubMed ID: 12524416
[TBL] [Abstract][Full Text] [Related]
54. Divergent effects of irritants on the gastric mucosa in rats during various stages after bile duct ligation.
Ackerman Z; Karmeli F; Pappo O
J Gastroenterol Hepatol; 2010 Jun; 25(6):1170-5. PubMed ID: 20594235
[TBL] [Abstract][Full Text] [Related]
55. Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects.
Poo JL; Jiménez W; María Muñoz R; Bosch-Marcé M; Bordas N; Morales-Ruiz M; Pérez M; Deulofeu R; Solé M; Arroyo V; Rodés J
Gastroenterology; 1999 Jan; 116(1):161-7. PubMed ID: 9869614
[TBL] [Abstract][Full Text] [Related]
56. Protective effects of recombinant human growth hormone on cirrhotic rats.
Chen S; Wang HT; Yang B; Fu YR; Ou QJ
World J Gastroenterol; 2004 Oct; 10(19):2894-7. PubMed ID: 15334695
[TBL] [Abstract][Full Text] [Related]
57. Effect of short-term administration of prostaglandin E1 on viability after ischemia/reperfusion injury with extended hepatectomy in cirrhotic rat liver.
Hossain MA; Izuishi K; Maeta H
World J Surg; 2003 Oct; 27(10):1155-60. PubMed ID: 12925901
[TBL] [Abstract][Full Text] [Related]
58. Gastroprotective and safety effects of WIN-34B, a novel treatment for osteoarthritis, compared to NSAIDs.
Huh JE; Lee WI; Seo BK; Baek YH; Lee JD; Choi DY; Park DS
J Ethnopharmacol; 2011 Sep; 137(2):1011-7. PubMed ID: 21782922
[TBL] [Abstract][Full Text] [Related]
59. Effect of long-term acid gastric inhibition on bacterial translocation in cirrhotic rats.
Sánchez E; Soriano G; Mirelis B; Gonzalez B; Nieto JC; Vidal S; Guarner-Argente C; Juárez C; Monés J; Guarner C
Eur J Gastroenterol Hepatol; 2015 May; 27(5):570-6. PubMed ID: 25822866
[TBL] [Abstract][Full Text] [Related]
60. Long-term administration of aqueous garlic extract (AGE) alleviates liver fibrosis and oxidative damage induced by biliary obstruction in rats.
Gedik N; Kabasakal L; Sehirli O; Ercan F; Sirvanci S; Keyer-Uysal M; Sener G
Life Sci; 2005 Apr; 76(22):2593-606. PubMed ID: 15769483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
